(SS), progressive systemic sclerosis (PSS), polymyalgia rheumatica with or without Horton's arteritis (PMR-HA), ankylosing spondylitis (AS), psoriatic arthritis (PA), and gout.23 We suggested that in the above mentioned diseases thrombocytosis should be considered as a nonspecific inflammation index, even if less useful than those commonly investigated. The clinician must therefore not be surprised to find thrombocytosis in a patient suffering from one of the above mentioned diseases. On the contrary, thrombocytopenia must lead to a careful evaluation.
Actually we never found thrombocytopenia in patients with JCA (n=49), PMR-HA (n=14), AS (n=32), PA (n=36), SS (n=10), or gout (n=20). As 
